On Wednesday, Zomedica Corp (ZOM) stock saw a modest uptick, ending the day at $0.14 which represents no change from the prior close of of $0.14. The stock opened at $0.14 and touched a low of $0.13 ...

NYSEAM:ZOM) Zomedica Announces License & Supply Agreement with Cresilon Inc. to Market and Sell Vetigel(R) Hemostatic Gel in the Animal Health Market ...

ZOM Stock Performance and Moving Averages. In recent trading, Zomedica Corp (ZOM) stock price has shown some volatility, fluctuating 21.30% over the last five trades and 12.14% ov ...

High prices could scare off would-be investors, but momentum abounds. The stock market climbed to record highs in 2024, extending banner gains achieved the previous year. The S&P 500 -- the index ...

It’s all on Santa’s shoulders. The kickoff of the “Santa Claus rally” period in Tuesday’s holiday-shortened trading session saw the S&P 500 SPX jump 1.1%, erasing a December decline as ...

The stock market will be closed on Christmas Day in observance of the federal holiday in the U.S. You can read more about this week’s holiday trading hours here. The U.S. bond market will stay ...

Discover the latest stocks recommended by top Wall Street analysts, all in one place with Analyst Top Stocks Make smarter investments with weekly expert stock picks from the Smart Investor ...

Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for ZOM is Buy with a score of 5.00.

On Monday, Zomedica Corp. (AMEX:ZOM) disclosed the launch of two new canine assays for its TRUFORMA In-Clinic Biosensor Testing Platform. Zomedica’s progesterone test quantitatively measures ...

Price Action: ZOM shares are down 4.31% at $0.1199 at the last check on Monday.